Home » NHS Could Save $135 Million A Year If Avastin Used in Eye Disease-Study
NHS Could Save $135 Million A Year If Avastin Used in Eye Disease-Study
The UK’s publicly-funded National Health Service could save $135 million a year if it replaced a Novartis-marketed treatment for a common eye disease in elderly people with a cheaper, yet unapproved, rival drug from Roche, a new study found.
The Wall Street Journal
The Wall Street Journal
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May